MIMIVAX INC. — Form D
MIMIVAX INC. of BUFFALO, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-12. The offering totals $5.8M, of which $5.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-07-12
- Form: D
- Accession: 0002027238-24-000005
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $5.8M
- Amount sold: $5.8M
- Minimum investment: $10K
- Investors: 16
- Date of first sale: 2023-10-06
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-518591
Issuer
- Name: MIMIVAX INC.
- CIK: 0002027238
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: ELM & CARLTON STREETS, BUFFALO, NY, 14263
- Phone: 7168535100
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Michael Ciesielski | Director | Buffalo, NY |
| Robert Fenstermaker | Director | Buffalo, NY |
| Scott Friedman | Director | Pittsburgh, PA |
| Jeremy Jacobs Jr. | Director | Buffalo, NY |
| Michael Sexton | Director | Buffalo, NY |
| Michael Ciesielski | Executive Officer | Buffalo, NY |
More